warnings
WARNINGS Naftin ® Cream and Gel, 1% are for topical use only and not for ophthalmic use.
FDA label 2dc4926b-1c54-4e3d-82af-e4ae8823e7fd
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- SPL set ID
- f4b6c5d8-615c-47d6-8ad9-523c7ab146af
- SPL ID
- 2dc4926b-1c54-4e3d-82af-e4ae8823e7fd
- Version
- 10
- Effective date
- 2013-04-25
- Source export date
- 2026-08-08
- Source partition
- 3
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-08-08/fb2175520ba436c0a81d623fd2a743c12c69c2188c898ffb9cc87c6b64d4a6cd/drug-label-0003-of-0014.json.zip
- Source manifest SHA-256
- b39f3b00ad50d2e1b32aaf429248c6081e8799b35bce715b4fccb8cfa1ac4546
- Import run
- 20260810T161303Z
- Imported at
- 2026-08-10 16:32:49
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| spl id | 2dc4926b-1c54-4e3d-82af-e4ae8823e7fd | id | |
| spl set id | f4b6c5d8-615c-47d6-8ad9-523c7ab146af | set_id |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS During clinical trials with Naftin ® Cream, 1%, the incidence of adverse reactions was as follows: burning/stinging (6%), dryness (3%), erythema (2%), itching (2%), local irritation (2%). During clinical trials with Naftin ® Gel, 1%. the incidence of adverse reactions was as follows: burning Istinging (5.0%), itching (1.0%), erythema (0.5%), rash (0.5%), skin tenderness (0.5%).